T cells can help you catch Lyme disease early.

In studies, T-Detect™ Lyme detected disease earlier and more accurately than the leading tests.1,2

T cells can help you catch Lyme disease early.

In studies, T-Detect™ Lyme detected disease earlier and more accurately than the leading tests.1,2

Suspect you have early Lyme disease?

Ask your doctor about T-Detect Lyme.

Getting an early diagnosis of Lyme disease is critical for adequate treatment. Whether you are among the 40-50% of patients with a bullseye-shaped rash, suspect you were bitten by a tick, or are experiencing unexplained flu-like symptoms after possibly being exposed to a tick, it’s important to get tested for Lyme disease quickly. However, today’s standard antibody tests may miss up to 75% of Lyme disease cases in the acute, or early, phase of infection.1,3

A new test, called T-Detect™ Lyme, can help. T-Detect Lyme is a new way of detecting Lyme disease as early as four days within symptoms beginning. Only available from your doctor and administered as a simple blood test, T-Detect Lyme is 1.5 times as sensitive as the leading test, standard two-tiered testing (STTT), within the early stages of Lyme disease, and three times as sensitive within the first four days.1,2

Sensitivity

T-Detect Lyme Sensitivity Patients

How T-Detect Lyme works

T-Detect Lyme uses your body’s T cells—a type of white blood cells—to detect whether your immune system has responded to Borrelia burgdorferi, the bacterium that causes Lyme disease.

In many cases of early Lyme disease, a detectable antibody response may be absent, but T-cell responses can arise earlier than antibodies. When T cells are activated by Borrelia burgdorferi, T-Detect Lyme can use them to find evidence of Lyme disease that may be missed by STTT and provide a reliable diagnosis.

In a recent study among patients with early Lyme disease, T-Detect Lyme had 1.5 times greater sensitivity than STTT in patients who presented with a bullseye rash2. In another study, T-Detect Lyme showed three times greater sensitivity than STTT in the first four days after symptoms appeared.1

Learn more about the role of T cells

T-Detect Lyme Contact You Doctor
T-Detect Lyme is not yet available in New York

Sign up here to receive a notification when T-Detect Lyme is available in New York.

References

  1. Greissl J, Pesesky M, Dalai SC, et al. Immunosequencing of the T-cell receptor repertoire reveals signatures specific for diagnosis and characterization of early Lyme disease. MedRxIv. 2021. https://doi.org/10.1101/2021.07.30.21261353.
  2. Data on file. Adaptive Biotechnologies. 2022.
  3. Marques AR. Revisiting the Lyme disease serodiagnostic algorithm: the momentum gathers. J Clin Microbiol. 2018 Jul 26. doi:10.1128/JCM.00749-18

T-Detect Lyme is not available in New York.

T-Detect Lyme is for prescription use only. For in vitro diagnostic use only. The CLIA laboratory-developed test (LDT) service has not been cleared or approved by the U.S. Food and Drug Administration (FDA) for this intended use. T-Detect is not indicated for use in patients under age 18.